MCM
RARE icon

MAI Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

MAI Capital Management’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$186K Buy
+8,884
New +$200K ﹤0.01% 1503
2025
Q4 		– Sell
-47
Closed -$1.41K – 4464
2025
Q3 		$1.41K Sell
47
-153
-77% -$4.59K ﹤0.01% 3397
2025
Q2 		$7.27K Buy
200
+147
+277% +$5.3K ﹤0.01% 2886
2025
Q1 		$1.92K Hold
53
– – ﹤0.01% 2981
2024
Q4 		$2.23K Buy
+53
New +$2.63K ﹤0.01% 3009

Other funds holding RARE

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return